Overall Morningstar Ratings as of 9/30/2024. Ratings are based on risk adjusted total returns, are determined monthly and are subject to change.
Equity Dividend Fund rated against 1,085 Large Value Funds*; Large Cap Focus Growth* rated against 1,076 Large Growth Funds. Mid-Cap Value rated against 375 Mid-Cap Value Funds. Mid-Cap Growth rated against 511 Mid-Cap Growth Funds*. Sustainable Advantage Large Cap Core* rated against 1,292 US Large Blend funds. Advantage International rated against 667 Foreign Large Blends funds. U.S. Equity Factor Rotation ETF rated against 1,292 US Large Blends funds. Emerging Markets Fund rated against 711 Diversified Emerging Markets Funds. International Fund rated against 340 US Fund Foreign Large Blend funds. **International Dividend rated against 667 Foreign Large Blend Funds. Prior to close of business on 11/15/2024, the Fund operated as an open-end mutual fund. **Health Sciences Opportunities Fund rated against 158 Health Funds. Technology Opportunities rated against 235 Technology Funds. High Equity Income rated against 77 Derivative Income Funds.
2: Prior to close of business on 11/15/2024, the Fund operated as an open-end mutual fund. The Fund has an identical investment objective and substantially similar investment strategies and investment risk profiles as the predecessor mutual fund. Performance for the periods prior to 6/12/17 shown above is based on the investment process and investment strategies utilized by the predecessor mutual fund when it followed a different investment objective, investment process and investment strategies under the name “BlackRock International Opportunities Portfolio.” The NAV returns are the returns of the Institutional Class Shares of the predecessor mutual fund prior to the Fund's commencement of operations, which had structural, regulatory, expense, and fee differences that may result in performance differences over time. Prior to the Fund's listing on 11/18/2024, the market price performance of the Fund uses the NAV returns of the Institutional Class Shares of the predecessor mutual fund as proxy market price returns. Please refer to the current prospectus for further information.
As of 9/30/2024, the Equity Dividend Fund received a Morningstar Rating of 3 stars for the 3-year period, 3 stars for the 5-year period and 4 stars for the 10-year period, rated against 1,085, 1,031 and 804 Large Value Funds, respectively. The Large Cap Focus Growth Fund received a Morningstar Rating of 2 stars for the 3-year period, 3 stars for the 5-year period and 4 stars for the 10-year period, rated against 1,076, 1,005 and 788 Large Growth Funds, respectively. Mid-Cap Value Fund received a Morningstar Rating of 3 stars for the 3-year period, 4 stars for the 5-year period and 4 stars for the 10-year period, rated against 375, 362 and 282 Mid-Cap Value Funds, respectively. The Mid-Cap Growth Equity Fund received a Morningstar Rating of 2 stars for the 3-year period, 2 stars for the 5-year period and 4 stars for the 10-year period, rated against 511, 476 and 378 Mid-Cap Growth Funds, respectively. The Sustainable Large Cap Core Fund received a Morningstar Rating of 3 stars for the 3-year period and 4 stars for the 5-year period, rated against 1,292 and 1,189 Large Blend Funds, respectively. The Advantage International received a Morningstar Rating of 5 stars for the 3-year period, 4 stars for the 5-year period and 4 stars for the 10-year period, rated against 667, 629 and 422 US Foreign Large Blend Funds, respectively. The U.S. Equity Factor Rotation ETF received a Morningstar Rating of 5 stars for the 3-year period, 4 stars for the 5-year period and 0 stars for the 10-year period, rated against 1,292, 1,189 and 895 Diversified Emerging Mkts Funds, respectively. The Emerging Markets Fund received a Morningstar Rating of 2 stars for the 3-year period, 3 stars for the 5-year period and 426 stars for the 10-year period, rated against 711, 629 and 426 Diversified Emerging Mkts Funds, respectively. The International Fund received a Morningstar Rating of 3 star for the 3-year period, 4 stars for the 5-year period and 4 stars for the 10-year period, rated against 340, 327 and 244 Foreign Large Blend Funds, respectively. The International Dividend received a Morningstar Rating of 5 stars for the 3-year period, 5 stars for the 5-year period and 4 stars for the 10-year period, rated against 667, 629 and 422 US Foreign Large Blend Funds, respectively. The Health Sciences Opportunities Fund received a Morningstar Rating of 4 stars for the 3-year period, 4 stars for the 5-year period and 5 stars for the 10-year period, rated against 158, 146 and 113 Health Funds, respectively. The Technology Opportunities Fund received a Morningstar Rating of 3 stars for the 3-year period, 3 stars for the 5-year period and 4 stars for the 10-year period, rated against 235, 202 and 158 Technology Funds, respectively. The High Equity Income Fund received a Morningstar Rating of 3 stars for the 3-year period, 3 stars for the 5-year period and 4 stars for the 10-year period, rated against 77, 67 and 37 Options-based Funds, respectively.
Performance results represent past performance and are no guarantee of future results.
Performance data represents past performance and does not guarantee future results. Investment return and principal value will fluctuate with market conditions and may be lower or higher when you sell your shares. Current performance may differ from the performance shown. For most recent month-end performance and standardized performance, click on the fund names above.
† Source: Equity Dividend: 1 Year 830/1,173; 3 Year 741/1,085; 5 Year 611/1,031; 10 Year 217/804. Large Cap Focus Growth: 1 Year 331/1,141; 3 Year 668/1,076; 5 Year 377/1,005; 10 Year 134/788. Mid-Cap Value: 1 Year 238/393; 3 Year 188/375; 5 Year 85/362; 10 Year 64/282. Mid-Cap Growth Equity: 1 Year 332/531; 3 Year 404/511; 5 Year 345/476; 10 Year 60/378. Sustainable Advantage Large Cap Core: 1 Year 284/1,414; 3 Year 622/1,292; 5 Year 205/1,189; 10 Year /895. Advantage International: 1 Year 147/717; 3 Year 26/667; 5 Year 103/629; 10 Year 43/422. Emerging Markets: 1 Year 708/795; 3 Year 525/711; 5 Year 380/629; 10 Year 153/426. International Fund: 1 Year 131/354; 3 Year 247/340; 5 Year 73/327; 10 Year 69/244. International Dividend: 1 Year 351/717; 3 Year 25/667; 5 Year 92/629; 10 Year 143/422. Health Sciences Opportunities: 1 Year 112/174; 3 Year 48/158; 5 Year 56/146; 10 Year 4/113. Technology Opportunities: 1 Year 49/265; 3 Year 156/235; 5 Year 76/202; 10 Year 30/158. High Equity Income: 1 Year 44/109; 3 Year 20/77; 5 Year 17/67; 10 Year 7/37.
Ratings based on risk-adjusted total return, determined monthly and subject to change.
The Morningstar Rating for funds, or "star rating," is calculated for managed products (including mutual funds, variable annuity and variable life subaccounts, exchange-traded funds, closed-end funds, and separate accounts) with at least a three-year history. Exchange-traded funds and open-ended mutual funds are considered a single population for comparative purposes. It is calculated based on a Morningstar Risk-Adjusted Return measure that accounts for variation in a managed product's monthly excess performance, placing more emphasis on downward variations and rewarding consistent performance. The top 10% of products in each product category receive 5 stars, the next 22.5% receive 4 stars, the next 35% receive 3 stars, the next 22.5% receive 2 stars, and the bottom 10% receive 1 star. The Overall Morningstar Rating for a managed product is derived from a weighted average of the performance figures associated with its three-, five-, and 10-year (if applicable) Morningstar Rating metrics. The weights are: 100% three-year rating for 36-59 months of total returns, 60% five-year rating/40% three-year rating for 60-119 months of total returns, and 50% 10-year rating/30% five-year rating/20% three-year rating for 120 or more months of total returns. While the 10-year overall star rating formula seems to give the most weight to the 10-year period, the most recent three-year period actually has the greatest impact because it is included in all three rating periods.
